• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

锡(II)和锡(IV)配合物,含有氧三角配位体 [(-CR)Co{P(OEt)O}],(R = H,Me;Et = -CH),作为有效的炎症介质抑制剂:对血小板激活因子(PAF)和凝血酶的细胞毒性性质和生物活性。

Tin(II) and Tin(IV) Complexes Incorporating the Oxygen Tripodal Ligands [(-CR)Co{P(OEt)O}], (R = H, Me; Et = -CH) as Potent Inflammatory Mediator Inhibitors: Cytotoxic Properties and Biological Activities against the Platelet-Activating Factor (PAF) and Thrombin.

机构信息

Laboratory of Inorganic Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece.

Department of Environmental Engineering, School of Engineering, University of Patras, 26504 Patras, Greece.

出版信息

Molecules. 2023 Feb 16;28(4):1859. doi: 10.3390/molecules28041859.

DOI:10.3390/molecules28041859
PMID:36838847
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9964123/
Abstract

Metal complexes displaying antiplatelet properties is a promising research area. In our methodology, Platelet-Activating Factor (PAF), the most potent lipid pro-inflammatory mediator, serves as a biological probe. The antiplatelet activity is exerted by the inhibition of the PAF-induced aggregation in washed rabbit platelets (WRPs) and in rabbit plasma rich in platelets (rPRPs). Herein, the synthesis and biological investigation of a series of organometallic tin(II) and tin(IV) complexes, featuring the oxygen tripodal Kläui ligands [(-CR)Co{P(OEt)O}], {R = H, (L); Me (L*)}, are reported. Reaction of NaL () and NaL* () with SnCl, yielded the rare four-coordinate LSnCl () and LSnCl () complexes. Accordingly, LSnPh () and LSnPh () were prepared, starting from PhSnCl. Characterization includes spectroscopy and X-ray diffraction studies for , and . The antiplatelet activity of the lead complexes and (IC = 0.5 μΜ) is superior compared to that of and , while both complexes display a pronounced inhibitory activity against thrombin (IC = 1.8 μM and 0.6 μM). The in vitro cytotoxic activities of and on human Jurkat T lymphoblastic tumor cell line is higher than that of cisplatin.

摘要

具有抗血小板特性的金属配合物是一个很有前途的研究领域。在我们的方法中,血小板激活因子(PAF),作为一种最有效的脂质促炎介质,作为生物探针。抗血小板活性是通过抑制血小板激活因子诱导的洗涤兔血小板(WRP)和富含血小板的兔血浆(rPRP)聚集来发挥的。本文报道了一系列具有氧三角架 Kläui 配体[(-CR)Co{P(OEt)O}]的有机锡(II)和锡(IV)配合物的合成和生物学研究,{R = H,(L);Me(L*)}。NaL()和 NaL*()与 SnCl 的反应生成了罕见的四配位 LSnCl()和 LSnCl()配合物。相应地,从 PhSnCl 开始制备了 LSnPh()和 LSnPh()。表征包括光谱和 X 射线衍射研究。对于 、 和 ,铅配合物 和 (IC = 0.5 μΜ)的抗血小板活性优于 和 ,而这两种配合物对凝血酶均显示出明显的抑制活性(IC = 1.8 μM 和 0.6 μM)。对人 Jurkat T 淋巴母细胞瘤细胞系的 和 的体外细胞毒性活性高于顺铂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0769/9964123/9c511a9d35a2/molecules-28-01859-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0769/9964123/fa543ed72979/molecules-28-01859-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0769/9964123/cab785135940/molecules-28-01859-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0769/9964123/4698b56be2b8/molecules-28-01859-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0769/9964123/31df4674e6be/molecules-28-01859-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0769/9964123/2bb4888b6f84/molecules-28-01859-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0769/9964123/9fb99bfa75a6/molecules-28-01859-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0769/9964123/9c511a9d35a2/molecules-28-01859-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0769/9964123/fa543ed72979/molecules-28-01859-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0769/9964123/cab785135940/molecules-28-01859-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0769/9964123/4698b56be2b8/molecules-28-01859-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0769/9964123/31df4674e6be/molecules-28-01859-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0769/9964123/2bb4888b6f84/molecules-28-01859-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0769/9964123/9fb99bfa75a6/molecules-28-01859-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0769/9964123/9c511a9d35a2/molecules-28-01859-g006.jpg

相似文献

1
Tin(II) and Tin(IV) Complexes Incorporating the Oxygen Tripodal Ligands [(-CR)Co{P(OEt)O}], (R = H, Me; Et = -CH) as Potent Inflammatory Mediator Inhibitors: Cytotoxic Properties and Biological Activities against the Platelet-Activating Factor (PAF) and Thrombin.锡(II)和锡(IV)配合物,含有氧三角配位体 [(-CR)Co{P(OEt)O}],(R = H,Me;Et = -CH),作为有效的炎症介质抑制剂:对血小板激活因子(PAF)和凝血酶的细胞毒性性质和生物活性。
Molecules. 2023 Feb 16;28(4):1859. doi: 10.3390/molecules28041859.
2
First-Row Transition Metal Complexes Incorporating the 2-(2'-pyridyl)quinoxaline Ligand (pqx), as Potent Inflammatory Mediators: Cytotoxic Properties and Biological Activities against the Platelet-Activating Factor (PAF) and Thrombin.第一过渡金属配合物结合 2-(2'-吡啶基)喹喔啉配体(pqx)作为有效的炎症介质:对血小板激活因子(PAF)和凝血酶的细胞毒性性质和生物学活性。
Molecules. 2023 Oct 1;28(19):6899. doi: 10.3390/molecules28196899.
3
In vitro anti-inflammatory and anti-coagulant effects of antibiotics towards Platelet Activating Factor and thrombin.抗生素对血小板激活因子和凝血酶的体外抗炎和抗凝作用。
J Inflamm (Lond). 2011 Jul 7;8:17. doi: 10.1186/1476-9255-8-17.
4
Two different sites of action for platelet activating factor and 1-O-alkyl-2-O-methyl-sn-glycero-3-phosphocholine on platelets and leukemic cells.血小板活化因子和1-O-烷基-2-O-甲基-sn-甘油-3-磷酸胆碱在血小板和白血病细胞上的两种不同作用位点。
Biochem Cell Biol. 1992 Feb;70(2):129-35. doi: 10.1139/o92-019.
5
Oxidizing Cerium(IV) Alkoxide Complexes Supported by the Kläui Ligand [Co(η-CH){P(O)(OEt)}]: Synthesis, Structure, and Redox Reactivity.由克劳伊配体[Co(η-CH){P(O)(OEt)}]支撑的氧化铈(IV)醇盐配合物:合成、结构及氧化还原反应活性
Inorg Chem. 2021 Feb 15;60(4):2261-2270. doi: 10.1021/acs.inorgchem.0c03105. Epub 2021 Jan 27.
6
Hydrolysis of bis(p-nitrophenyl)phosphate by tetravalent metal complexes with Klaui's oxygen tripodal ligand.Klaui 氧三角配位体的四价金属配合物对双(对硝基苯基)磷酸酯的水解作用。
Inorg Chem. 2010 Mar 1;49(5):2232-8. doi: 10.1021/ic902018u.
7
Piano-stool ruthenium(II) complexes with maleimide and phosphine or phosphite ligands: synthesis and activity against normal and cancer cells.含马来酰亚胺和膦或亚磷酸配体的钢琴凳式钌(II)配合物:合成及对正常和癌细胞的活性。
Dalton Trans. 2023 Mar 28;52(13):4237-4250. doi: 10.1039/d2dt04083b.
8
Half-sandwich hydride complexes of ruthenium with bidentate phosphinoamine ligands: proton-transfer reactions to [(C5R5)RuH(L)] [R = H, Me; L = dippae, (R,R)-dippach].钌与双齿膦胺配体形成的半夹心氢化物配合物:与[(C5R5)RuH(L)]的质子转移反应[R = H, Me; L = dippae, (R,R)-dippach]
Inorg Chem. 2007 Feb 5;46(3):1001-12. doi: 10.1021/ic061745u.
9
Synthesis, Structure, and Reactivity of a Tetranuclear Cerium(IV) Oxo Cluster Supported by the Kläui Tripodal Ligand [Co(η(5) -C5 H5 ){P(O)(OEt)2 }3 ](.).由克劳伊三脚架配体[Co(η(5)-C5H5){P(O)(OEt)2}3](.)支撑的四核铈(IV)氧簇的合成、结构与反应活性
Chemistry. 2015 Nov 2;21(45):16126-35. doi: 10.1002/chem.201502173. Epub 2015 Sep 14.
10
Tetravalent cerium pseudohalide complexes supported by the Kläui tripodal ligand [Co(η-CH){P(O)(OEt)}].由克劳伊三脚架配体[Co(η-CH){P(O)(OEt)}]支撑的四价铈拟卤化物配合物。
Dalton Trans. 2016 Nov 15;45(45):18163-18170. doi: 10.1039/c6dt03740b.

引用本文的文献

1
First-Row Transition Metal Complexes Incorporating the 2-(2'-pyridyl)quinoxaline Ligand (pqx), as Potent Inflammatory Mediators: Cytotoxic Properties and Biological Activities against the Platelet-Activating Factor (PAF) and Thrombin.第一过渡金属配合物结合 2-(2'-吡啶基)喹喔啉配体(pqx)作为有效的炎症介质:对血小板激活因子(PAF)和凝血酶的细胞毒性性质和生物学活性。
Molecules. 2023 Oct 1;28(19):6899. doi: 10.3390/molecules28196899.

本文引用的文献

1
Recent advances in biological activities of rhodium complexes: Their applications in drug discovery research.铑配合物生物活性的最新进展:在药物发现研究中的应用。
Eur J Med Chem. 2021 Apr 15;216:113308. doi: 10.1016/j.ejmech.2021.113308. Epub 2021 Feb 23.
2
The Proven Versatility of CpTiCl.CpTiCl 的多方面性能已得到证实。
J Org Chem. 2021 Jan 15;86(2):1311-1329. doi: 10.1021/acs.joc.0c01233. Epub 2020 Nov 4.
3
One Ligand, One Metal, Seven Oxidation States: Stable Technetium Complexes with the "Kläui Ligand".一种配体,一种金属,七种氧化态:具有“Kläui 配体”的稳定锝配合物。
Inorg Chem. 2020 Jul 6;59(13):9396-9405. doi: 10.1021/acs.inorgchem.0c01264. Epub 2020 Jun 23.
4
The Effects of Oxidation on the Antithrombotic Properties of Tea Lipids Against PAF, Thrombin, Collagen, and ADP.氧化对茶脂抗血小板活化因子、凝血酶、胶原蛋白及二磷酸腺苷的抗血栓形成特性的影响
Foods. 2020 Mar 26;9(4):385. doi: 10.3390/foods9040385.
5
Forty Years Since the Structural Elucidation of Platelet-Activating Factor (PAF): Historical, Current, and Future Research Perspectives.血小板激活因子(PAF)结构阐明四十年来:历史、当前和未来研究视角。
Molecules. 2019 Dec 3;24(23):4414. doi: 10.3390/molecules24234414.
6
Anti-proliferative and antitumor activity of organotin(IV) compounds. An overview of the last decade and future perspectives.有机锡(IV)化合物的抗增殖和抗肿瘤活性。过去十年的概述和未来展望。
J Inorg Biochem. 2019 May;194:114-152. doi: 10.1016/j.jinorgbio.2019.02.003. Epub 2019 Feb 13.
7
In vitro Anti-atherogenic Properties of N-Heterocyclic Carbene Aurate(I) Compounds.N-杂环卡宾金(I)配合物的体外抗动脉粥样硬化特性。
ChemMedChem. 2018 Dec 6;13(23):2484-2487. doi: 10.1002/cmdc.201800601. Epub 2018 Nov 27.
8
Progress in the Development of Platelet-Activating Factor Receptor (PAFr) Antagonists and Applications in the Treatment of Inflammatory Diseases.血小板激活因子受体 (PAFr) 拮抗剂的研究进展及其在炎症性疾病治疗中的应用。
ChemMedChem. 2018 Sep 19;13(18):1873-1884. doi: 10.1002/cmdc.201800401. Epub 2018 Aug 16.
9
Ruthenium-conjugated chrysin analogues modulate platelet activity, thrombus formation and haemostasis with enhanced efficacy.钌缀合白杨素类似物可增强疗效调节血小板活性、血栓形成和止血作用。
Sci Rep. 2017 Jul 18;7(1):5738. doi: 10.1038/s41598-017-05936-3.
10
A Review on Platelet Activating Factor Inhibitors: Could a New Class of Potent Metal-Based Anti-Inflammatory Drugs Induce Anticancer Properties?血小板活化因子抑制剂综述:一类新型强效金属基抗炎药物能否诱导抗癌特性?
Bioinorg Chem Appl. 2017;2017:6947034. doi: 10.1155/2017/6947034. Epub 2017 Mar 28.